Your browser doesn't support javascript.
loading
Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG.
Franklin, Cindy; Mohr, Peter; Bluhm, Leonie; Meier, Friedegund; Garzarolli, Marlene; Weichenthal, Michael; Kähler, Katharina; Grimmelmann, Imke; Gutzmer, Ralf; Utikal, Jochen; Terheyden, Patrick; Herbst, Rudolf; Haferkamp, Sebastian; Pfoehler, Claudia; Forschner, Andrea; Leiter, Ulrike; Ziller, Fabian; Meiss, Frank; Ulrich, Jens; Kreuter, Alexander; Gebhardt, Christoffer; Welzel, Julia; Schilling, Bastian; Kaatz, Martin; Scharfetter-Kochanek, Karin; Dippel, Edgar; Nashan, Dorothee; Sachse, Michael; Weishaupt, Carsten; Löffler, Harald; Gambichler, Thilo; Loquai, Carmen; Heinzerling, Lucie; Grabbe, Stephan; Debus, Dirk; Schley, Gaston; Hassel, Jessica C; Weyandt, Gerhard; Trommer, Maike; Lodde, Georg; Placke, Jan-Malte; Zimmer, Lisa; Livingstone, Elisabeth; Becker, Jürgen Christian; Horn, Susanne; Schadendorf, Dirk; Ugurel, Selma.
Afiliación
  • Franklin C; Department of Dermatology and Venereology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany cindy.franklin@uk-koeln.de.
  • Mohr P; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIO ABCD), Cologne, Germany.
  • Bluhm L; Department of Dermatology, Elbe-Kliniken Buxtehude, Buxtehude, Germany.
  • Meier F; Department of Dermatology, Elbe-Kliniken Buxtehude, Buxtehude, Germany.
  • Garzarolli M; Department of Dermatology, University Hospital Carl Gustav Carus, TU Dresden and, Skin Cancer Center at the University Cancer Center Dresden and National Center for Tumor Diseases (NCT), Dresden, Germany.
  • Weichenthal M; Department of Dermatology, University Hospital Carl Gustav Carus, TU Dresden and, Skin Cancer Center at the University Cancer Center Dresden and National Center for Tumor Diseases (NCT), Dresden, Germany.
  • Kähler K; Department of Dermatology, Skin Cancer Center, Schleswig-Holstein University Hospital, Campus Kiel, Kiel, Germany.
  • Grimmelmann I; Department of Dermatology, Skin Cancer Center, Schleswig-Holstein University Hospital, Campus Kiel, Kiel, Germany.
  • Gutzmer R; Skin Cancer Center Hannover, Department of Dermatology, Hannover Medical School, Hanover, Germany.
  • Utikal J; Department of Dermatology, Muehlenkreiskliniken Minden and Ruhr University Bochum, Minden, Germany.
  • Terheyden P; Skin Cancer Unit, German Cancer Research Center (DKFZ) and Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany.
  • Herbst R; Department of Dermatology, University of Lübeck and Schleswig-Holstein University Hospital, Campus Lübeck, Lübeck, Germany.
  • Haferkamp S; Department of Dermatology, HELIOS Klinikum Erfurt, Erfurt, Germany.
  • Pfoehler C; Department of Dermatology, University Hospital Regensburg, Regensburg, Germany.
  • Forschner A; Department of Dermatology, Saarland University Medical School, Homburg, Homburg/Saar, Germany.
  • Leiter U; Department of Dermatology, University Hospital Tübingen, Tübingen, Germany.
  • Ziller F; Department of Dermatology, University Hospital Tübingen, Tübingen, Germany.
  • Meiss F; Department of Dermatology, DRK Hospital Chemnitz-Rabenstein, Chemnitz, Germany.
  • Ulrich J; Department of Dermatology and Venereology, Medical Center, University of Freiburg, Freiburg im Breisgau, Germany.
  • Kreuter A; Department of Dermatology and Skin Cancer Center, Harzklinikum Dorothea Christiane Erxleben, Quedlinburg, Germany.
  • Gebhardt C; Department of Dermatology, Venereology and Allergology, Helios St. Elisabeth Klinik Oberhausen, University Witten-Herdecke, Oberhausen, Germany.
  • Welzel J; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Schilling B; Department of Dermatology and Allergology, University Hospital Augsburg, Augsburg, Germany.
  • Kaatz M; Department of Dermatology and Venereology, University Hospital Würzburg, Würzburg, Germany.
  • Scharfetter-Kochanek K; Department of Dermatology, SRH Wald-Klinikum Gera, Gera, Germany.
  • Dippel E; Department of Dermatology and Venereology, University Hospital Ulm, Ulm, Germany.
  • Nashan D; Department of Dermatology, Ludwigshafen Medical Center, Ludwigshafen, Germany.
  • Sachse M; Department of Dermatology, Hospital of Dortmund, Dortmund, Germany.
  • Weishaupt C; Skin Cancer Center, Department of Dermatology, Klinikum Bremerhaven Reinkenheide, Bremerhaven, Germany.
  • Löffler H; Department of Dermatology, University Hospital of Muenster, Muenster, Germany.
  • Gambichler T; Department of Dermatology, SLK-Kliniken Heilbronn, Heilbronn, Germany.
  • Loquai C; Department of Dermatology, Ruhr-University Bochum, Bochum, Germany.
  • Heinzerling L; Department of Dermatology, Klinikum Bremen-Ost, Gesundheit Nord gGmbH, Bremen, Germany.
  • Grabbe S; Department of Dermatology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Debus D; Department of Dermatology and Allergology, Ludwig-Maximilian University, Munich, Germany.
  • Schley G; Department of Dermatology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Hassel JC; Department of Dermatology, Nuremberg General Hospital, Paracelsus Medical University, Nuremberg, Germany.
  • Weyandt G; Department of Dermatology and Venereology, Helios Klinikum Schwerin, Schwerin, Germany.
  • Trommer M; National Center for Tumor Diseases (NCT), Department of Dermatology, University Hospital Heidelberg, Heidelberg, Germany.
  • Lodde G; Department of Dermatology and Allergology, Hospital Bayreuth, Bayreuth, Germany.
  • Placke JM; Department of Radiation Oncology and Cyberknife Center, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Zimmer L; Department of Dermatology, Venereology and Allergology, University Hospital Essen and German Cancer Consortium (DKTK) Partner Site Essen, Essen, Germany.
  • Livingstone E; Department of Dermatology, Venereology and Allergology, University Hospital Essen and German Cancer Consortium (DKTK) Partner Site Essen, Essen, Germany.
  • Becker JC; Department of Dermatology, Venereology and Allergology, University Hospital Essen and German Cancer Consortium (DKTK) Partner Site Essen, Essen, Germany.
  • Horn S; Department of Dermatology, Venereology and Allergology, University Hospital Essen and German Cancer Consortium (DKTK) Partner Site Essen, Essen, Germany.
  • Schadendorf D; Department of Dermatology, Venereology and Allergology, University Hospital Essen and German Cancer Consortium (DKTK) Partner Site Essen, Essen, Germany.
  • Ugurel S; Translational Skin Cancer Research, German Cancer Consortium (DKTK), Deutsches Krebsforschungszentrum, Heidelberg, Germany.
J Immunother Cancer ; 11(4)2023 04.
Article en En | MEDLINE | ID: mdl-37028819
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Neoplasias Encefálicas / Melanoma Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Immunother Cancer Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Neoplasias Encefálicas / Melanoma Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Immunother Cancer Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido